| Assay ID | Title | Year | Journal | Article |
|---|
| AID660224 | In vivo displacement of [3H]Ketanserin from 5HT2A receptor in Sprague-Dawley rat dorsolateral frontal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660220 | In vivo displacement of [3H]8-OH-DPAT from 5HT1A receptor in Sprague-Dawley rat hippocampus CA1 region at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID659850 | Displacement of [3H]ketanserin from human recombinant 5HT2A receptor expressed in CHO cells after 60 mins by liquid scintillation counting | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660199 | In vivo displacement of [3H]SCH-23390 from dopamine D1 receptor in Sprague-Dawley rat hippocampus at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660217 | In vivo displacement of [3H]8-OH-DPAT from 5HT1A receptor in Sprague-Dawley rat nucleus accumbens at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660198 | In vivo displacement of [3H]SCH-23390 from dopamine D1 receptor in Sprague-Dawley rat lateral part of caudate putamen at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660218 | In vivo displacement of [3H]8-OH-DPAT from 5HT1A receptor in Sprague-Dawley rat medial part of caudate putamen at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660212 | In vivo displacement of [3H]Nemonapride from dopamine D4 receptor in Sprague-Dawley rat lateral part of caudate putamen at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660225 | In vivo displacement of [3H]Ketanserin from 5HT2A receptor in Sprague-Dawley rat nucleus accumbens at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660196 | In vivo displacement of [3H]SCH-23390 from dopamine D1 receptor in Sprague-Dawley rat nucleus accumbens at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660209 | In vivo displacement of [3H]Nemonapride from dopamine D4 receptor in Sprague-Dawley rat dorsolateral frontal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660204 | In vivo displacement of [3H]Nemonapride from dopamine D2 receptor in Sprague-Dawley rat medial of caudate putamen at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660221 | In vivo displacement of [3H]8-OH-DPAT from 5HT1A receptor in Sprague-Dawley rat hippocampus CA3 region at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660229 | In vivo displacement of [3H]Ketanserin from 5HT2A receptor in Sprague-Dawley rat hippocampus CA3 region at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660205 | In vivo displacement of [3H]Nemonapride from dopamine D2 receptor in Sprague-Dawley rat lateral of caudate putamen at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660219 | In vivo displacement of [3H]8-OH-DPAT from 5HT1A receptor in Sprague-Dawley rat lateral part of caudate putamen at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660203 | In vivo displacement of [3H]Nemonapride from dopamine D2 receptor in Sprague-Dawley rat nucleus accumbens at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660227 | In vivo displacement of [3H]Ketanserin from 5HT2A receptor in Sprague-Dawley rat lateral part of caudate putamen at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID659853 | Lipophilicity, log K of the compound in IAM-PC-DD2 HPLC column by UV method | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660194 | In vivo displacement of [3H]SCH-23390 from dopamine D1 receptor in Sprague-Dawley rat medial-prefrontal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660201 | In vivo displacement of [3H]Nemonapride from dopamine D2 receptor in Sprague-Dawley rat medial-prefrontal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660195 | In vivo displacement of [3H]SCH-23390 from dopamine D1 receptor in Sprague-Dawley rat dorsolateral frontal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660223 | In vivo displacement of [3H]Ketanserin from 5HT2A receptor in Sprague-Dawley rat medial-prefrontal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660211 | In vivo displacement of [3H]Nemonapride from dopamine D4 receptor in Sprague-Dawley rat medial part of caudate putamen at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660202 | In vivo displacement of [3H]Nemonapride from dopamine D2 receptor in Sprague-Dawley rat dorsolateral frontal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660206 | In vivo displacement of [3H]Nemonapride from dopamine D2 receptor in Sprague-Dawley rat hippocampus at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660222 | In vivo displacement of [3H]8-OH-DPAT from 5HT1A receptor in Sprague-Dawley rat entorhinal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660216 | In vivo displacement of [3H]8-OH-DPAT from 5HT1A receptor in Sprague-Dawley rat dorsolateral frontal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660228 | In vivo displacement of [3H]Ketanserin from 5HT2A receptor in Sprague-Dawley rat hippocampus CA1 region at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660208 | In vivo displacement of [3H]Nemonapride from dopamine D4 receptor in Sprague-Dawley rat medial-prefrontal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660207 | In vivo displacement of [3H]Nemonapride from dopamine D2 receptor in Sprague-Dawley rat entorhinal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660214 | In vivo displacement of [3H]Nemonapride from dopamine D4 receptor in Sprague-Dawley rat entorhinal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660215 | In vivo displacement of [3H]8-OH-DPAT from 5HT1A receptor in Sprague-Dawley rat medial-prefrontal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660226 | In vivo displacement of [3H]Ketanserin from 5HT2A receptor in Sprague-Dawley rat medial part of caudate putamen at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660230 | In vivo displacement of [3H]Ketanserin from 5HT2A receptor in Sprague-Dawley rat entorhinal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660197 | In vivo displacement of [3H]SCH-23390 from dopamine D1 receptor in Sprague-Dawley rat medial part of caudate putamen at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660210 | In vivo displacement of [3H]Nemonapride from dopamine D4 receptor in Sprague-Dawley rat nucleus accumbens at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660200 | In vivo displacement of [3H]SCH-23390 from dopamine D1 receptor in Sprague-Dawley rat entorhinal cortex at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID659851 | Displacement of [3H]-YM09151-2 from human cloned dopamine D4 receptor expressed in insect Sf9 cells after 60 mins by liquid scintillation counting | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID659849 | Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID659855 | Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor expressed in CHO cells at 10'-6 M after 60 mins by liquid scintillation counting | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| AID660213 | In vivo displacement of [3H]Nemonapride from dopamine D4 receptor in Sprague-Dawley rat hippocampus at 10 mg/kg, ip qd for 28 days by autoradiography relative to control | 2012 | Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
| New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |